Trending: Amgen to Buy Horizon Therapeutics in Blockbuster Deal
13 December 2022 - 3:07AM
Dow Jones News
10:36 ET -- Amgen Inc. is one of the most talked about companies
in the U.S. across all news items in the last 12 hours, according
to Factiva data. The biotechnology company has agreed to pay nearly
$28 billion to buy Horizon Therapeutics PLC in the biggest
healthcare deal of the year. Amgen shares are down 1.3%. Dow Jones
& Co. owns Factiva. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
December 12, 2022 10:52 ET (15:52 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Apr 2023 to Apr 2024